These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20718038)

  • 21. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity.
    Meuillet EJ; Mahadevan D; Berggren M; Coon A; Powis G
    Arch Biochem Biophys; 2004 Sep; 429(2):123-33. PubMed ID: 15313215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
    Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M
    Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-binding and activation mechanism of PTEN.
    Das S; Dixon JE; Cho W
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7491-6. PubMed ID: 12808147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line.
    Singh G; Odriozola L; Guan H; Kennedy CR; Chan AM
    BMC Cancer; 2011 Nov; 11():490. PubMed ID: 22103913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-molecule imaging of PI(4,5)P
    Yoshioka D; Fukushima S; Koteishi H; Okuno D; Ide T; Matsuoka S; Ueda M
    Commun Biol; 2020 Feb; 3(1):92. PubMed ID: 32111929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
    Smith IN; Thacker S; Jaini R; Eng C
    J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.
    Stiles BL
    Int J Biochem Cell Biol; 2009 Apr; 41(4):757-61. PubMed ID: 18950730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the PTEN phosphatase.
    Gericke A; Munson M; Ross AH
    Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.
    He X; Ni Y; Wang Y; Romigh T; Eng C
    Hum Mol Genet; 2011 Jan; 20(1):80-9. PubMed ID: 20926450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI(3)king apart PTEN's role in cancer.
    Zhang S; Yu D
    Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
    Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
    Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
    Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H
    Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN inhibits BMI1 function independently of its phosphatase activity.
    Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
    Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes.
    Kamen LA; Levinsohn J; Swanson JA
    Mol Biol Cell; 2007 Jul; 18(7):2463-72. PubMed ID: 17442886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN in Autism and Neurodevelopmental Disorders.
    Rademacher S; Eickholt BJ
    Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 31427284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
    Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
    Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
    Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.